Mucoadhesive properties of chitosan-coated ophthalmic lipid emulsion containing indomethacin in tear fluid

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 7, 2009, Pages 1266-1271

  Yamaguchi, Masazumi ^a   Ueda, Kayoko ^a   Isowaki, Akiharu ^a   Ohtori, Akira ^a   Takeuchi, Hirofumi ^b   Ohguro, Nobuyuki ^c   Tojo, Kakuji ^d  

^a SENJU PHARMACEUTICAL CO LTD   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d KYUSHU INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Chitosan; Computer simulation; Indomethacin; Lipid emulsion; Mucoadhesive; Tear fluid

Indexed keywords

ACETIC ACID; CASTOR OIL; CHITOSAN; EMULSIFYING AGENT; GLYCEROL; HYDROXYPROPYLMETHYLCELLULOSE; INDOMETACIN; LIPID EMULSION; MUCIN; POLYSORBATE 80;

ANIMAL TISSUE; AQUEOUS HUMOR; AREA UNDER THE CURVE; ARTICLE; CONJUNCTIVA; CONTROLLED STUDY; CORNEA; DRUG BIOAVAILABILITY; DRUG COATING; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG INSTILLATION; DRUG RETENTION; HALF LIFE TIME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; LACRIMAL FLUID; MALE; MAXIMUM PLASMA CONCENTRATION; MUCOADHESION; NONHUMAN; PARTICLE SIZE; RABBIT; SIMULATION; SURFACE PROPERTY; VISCOSITY; ZETA POTENTIAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AQUEOUS HUMOR; BIOLOGICAL AVAILABILITY; CASTOR OIL; CHITOSAN; DRUG CARRIERS; EMULSIONS; INDOMETHACIN; INSTILLATION, DRUG; MODELS, BIOLOGICAL; MUCINS; OPHTHALMIC SOLUTIONS; PARTICLE SIZE; RABBITS; TEARS; TISSUE ADHESIVES; VISCOSITY;

EID: 67650751095     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.1266     Document Type: Article

References (36)

1. Sultane Y., Jain R., Aqil M., Ali A., Curr. Drug Deliv., 3, 207-217 (2006).
2. Yamaguchi M., Yasueda S., Isowaki A., Yamamoto M., Kimura M., Inada K., Ohtori A., Int. J. Pharm., 301, 121-128 (2005).
3. Lallemand F., Felt-Baeyens O., Besseghir K., Behar-Cohen F., Gurny R., Eur. J. Pharm. Biopharm., 56, 307-318 (2003).
4. Calvo P., Alonso M. J., Vila-Jato J. L., Robinson J. R., J. Pharm. Pharmacol., 48, 1147-1152 (1996).
5. Nagarsenker M. S., Londhe V. Y., Nadkarni G. D., Int. J. Pharm., 190, 63-71 (1999).
6. Fitzgerald P., Hadgraft J., Kreuter J., Wilson G., Int. J. Pharm., 40, 81-84 (1987).
7. Smolin G., Okumoto M., Feiler S., Condon D., Am. J. Ophthalmol., 91, 220-225 (1981).
8. Losa C., Calvo P., Castro E., Vila-Jato J. L., Alonso M. J., J. Pharm. Pharmacol., 43, 548-552 (1991).
9. Davies N. M., Farr S. J., Hadgraft J., Kellaway I. W., Pharm. Res., 9, 1137-1144 (1992).
10. Kaur I. P., Garg A., Singa A. K., Aggarwal D., Int. J. Pharm., 269, 1-14 (2004).
11. Zimmer A., Kreuter J., Adv. Drug Deliv. Rev., 16, 61-73 (1995).
12. Felt O., Furrer P., Mayer J. M., Plazonnet B., Buri P., Gurny R., Int. J. Pharm., 180, 185-193 (1999).
13. Takeuchi H., Yamamoto H., Niwa T., Hino T., Kawashima Y., Pharm. Res., 13, 896-901 (1996).
14. Takeuchi H., Matsui Y., Yamamoto H., Kawashima Y., J. Controlled Release, 86, 235-242 (2003).
15. Takeuchi H., Thongborisute J., Matui Y., Sugihara H., Yamamoto H., Kawashima Y., Adv. Drug Deliv. Rev., 57, 1583-1594 (2005).
16. Aggarwal D., Kaur I. P., Int. J. Pharm., 290, 185-193 (1999).
17. De Campos A. M., Sanchez A., Alonso M. J., Int. J. Pharm., 224, 159-168 (2001).
18. De Campos A. M., Sanchez A., Gref R., Calvo P., Alonso M. J., Eur. J. Pharm. Sci., 20, 73-81 (2003).
19. Sanders D. R., Kraff M. C., Liberman H. L., Arch. Ophthalmol., 100, 558-590 (1982).
20. Palimeris G., Koliopoulos J., Velissaropoulos P., Ophthalmology, 100, 558-590 (1972).
21. Tojo K., Math. Biosci., 89, 53-77 (1988).
22. Tojo K., J. Chem. Eng. Japan, 22, 518-521 (1989).
23. Tojo K., Desai D. S., Chien Y. W., Proc. Int. Symp. Control. Rel. Bioact. Mater., 15, 133 (1988).
24. Caramella C., Bonferoni M. C., Rossi S., Ferrari F., Eur. J. Pharm. Biopharm., 40, 213-217 (1994).
25. Acheampong A. A., Shackleton M., Tang-Liu D. D.-S., Ding S., Stern M. E., Decker R., Curr. Eye Res., 18, 91-103 (1999).
26. Jumaa M., Müller B. W., Int. J. Pharm., 183, 175-184 (1999).
27. Mitra A. K., "Ophthalmic Drug Delivery Systems," Marcel Dekker Inc., New York, 1993.
28. Chrai S. S., Robinson J. R., J. Pharm. Sci., 63, 1218-1223 (1974).
29. Edman P., "Biopharmaceutics of Ocular Drug Delivery," CRC Press Inc., Florida, 1993.
30. De Vos A., Vervoort L., Kinget R., J. Pharm. Sci., 83, 641-643 (1994).
31. Pidgeon C., Ong S., Liu H., Qiu X., Pidgeon M., Dantzig A. H., Munroe J., Hornback W. J., Kasher J. S., Glunz L., Szczerba T., J. Med. Chem., 38, 590-594 (1995).
32. Maurice D. M., Mishima S., "Pharmacology of the Eye," Springer, New York, 1984.
33. Ludwig A., Adv. Drug Deliv. Rev., 57, 1595-1639 (2005).
34. Thongborisute J., Takeuchi H., Int. J. Pharm., 354, 204-209 (2008).
35. Yakubov G. E., Papagiannopoulous A., Rat E., Easton R. L., Waigh T. A., Biomacromolecules, 8, 3467-3477 (2007).
36. Gipson I. K., Hori Y., Argüeso P., Ocul. Surf., 2, 131-148 (2004).